Treatment of Pulmonary Embolism in an Extremely Obese Patient
Authors: Diepstraten, Jeroen1; Kralingen, Simone2; Snijder, Repke3; Hackeng, Christian4; Ramshorst, Bert5; Knibbe, Catherijne6
Source: Obesity Surgery, Volume 19, Number 8, August 2009 , pp. 1186-1189(4)
Publisher: Springer
- In this: publication
- By this: publisher
- In this Subject: Surgery
- By this author: Diepstraten, Jeroen ; Kralingen, Simone ; Snijder, Repke ; Hackeng, Christian ; Ramshorst, Bert ; Knibbe, Catherijne
Abstract:
Low-molecular-weight heparins are effective as initial therapy for pulmonary embolism (PE) in a weight-based dosing regimen up to known body weights of 160 kg. The present case reports an extremely obese man of 252 kg (body mass index (BMI) 74 kg/m2) with PE who was treated with tinzaparin, dosed on a body weight of 160 kg. Morbid obesity defined as a BMI higher than 40 kg/m2 is becoming more common in general practice, but there are no evidence-based drug dosing strategies for these patients. This case demonstrates the successful use of a maximum dose of 28,000 anti-Xa international units of tinzaparin for an extremely obese patient with proven PE, instead of the accepted doses of 175 IU/kg, as bridge therapy to a coumarin.Keywords: Anti-Xa activity; Low-molecular-weight heparin; Morbid obesity; Pulmonary embolism; Tinzaparin
Document Type: Research article
DOI: 10.1007/s11695-009-9886-7
Affiliations: 1: Department of Clinical Pharmacy, St. Antonius Hospital, P.O. Box 2500, 3430 EM, Nieuwegein, The Netherlands 2: Department of Anaesthesiology, St. Antonius Hospital, Nieuwegein, The Netherlands 3: Department of Pulmonary Diseases, St. Antonius Hospital, Nieuwegein, The Netherlands 4: Department of Clinical Chemistry, St. Antonius Hospital, Nieuwegein, The Netherlands 5: Department of Surgery, St. Antonius Hospital, Nieuwegein, The Netherlands 6: Department of Clinical Pharmacy, St. Antonius Hospital, P.O. Box 2500, 3430 EM, Nieuwegein, The Netherlands, Email: c.knibbe@antoniusziekenhuis.nl

Click here for Page Help